Interviews | BioPharmaTrend

Raj Indupuri: Better Data Management is Key for Clinical Trials

The digitalization of clinical trials and the adoption of artificial intelligence (AI) has been a hot topic for a number …

Alex Zhavoronkov: Linking Chemistry and Biology Using Artificial Intelligence

The team at Insilico Medicine has recently reported that they achieved a major milestone for their comprehensive artificial intelligence (AI)-based …

[Interview] How D-Wave Brings Quantum Computing Into Biology

In its 2020 Tech Trends report, CB Insights has profiled the 14 tech trends that it considers deserving attention in …

[Interview] This Company Brings Quantum Tech Into Protein Design

With several decades of advances in quantum theory and simultaneous progress in a number of software and hardware fields, we …

[Interview] A Company on the Cutting Edge of COVID-19 Vaccine Development

Recently, COVAXX announced it would soon enter human trials as the company is focused on rapidly developing a Multitope Peptide-based …

[Interview] A New Way To Work With Data In Life Sciences

Founded by renowned database researcher, Turing Award laureate MIT Professor Michael Stonebraker, Paradigm4 is not just any data analytics company …

[Interview] Expediting Drug Discovery Through Advanced Machine Learning

The application of next-generation data analytics tools, powered by machine learning and artificial intelligence (AI) components, has become a long-term …

[Interview] Shaping European AI Regulation To Secure Global Leadership In Healthcare

While the history of Artificial Intelligence (AI) field began in the distant 1950s, its practical value had largely remained limited …

[Interview] How COVID-19 Catalyzed AI-assisted Open Science Drug Discovery

Biopharma companies are now racing to find much-needed cures against SARS-CoV-2, a virus that caused the largest global pandemic of …

[Interview] Advancing Off-the-shelf Cellular Medicines to Fight COVID-19

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), a world leader in developing allogeneic (off-the-shelf) cellular medicines, just announced that the first COVID-19 infected …

[Interview] Hacking Metabolomics With AI To Improve Clinical Research

Personalized medicine has become a paradigm-shifting trend in healthcare - the hegemony of “one-size-fits-all” drugs is increasingly challenged by novel innovative …

[Interview] Building Canada’s Life Sciences Community and Thinking Global

Canada has a firm place in the global life sciences ecosystem, being the tenth largest market for pharmaceutical sales, and …